Back to search

A prospective, multicenter, randomized, parallel-group, open-label study of aripiprazole in the management of patients with schizophrenia or schizoaffective disorder in general psychiatric practice: Broad Effectiveness Trial With Aripiprazole (BETA)

Data up to Jan 2025

Published2006
Citations107
References38

Total Citations Per Year

Abstract

References (38)

ECDEU Assessment Manual for Psychopharmacology

1976 • 8,729 citations

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

2005 • 5,799 citations

Hudson et al.

1977 • 2,560 citations

Consensus Development Conference on Antipsychotic Drugs and Obesity and Diabetes

2004 • 1,437 citations

Prevalence of and Risk Factors for Medication Nonadherence in Patients With Schizophrenia

2002 • 1,303 citations

What does the PANSS mean?

2005 • 1,142 citations

Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis

2000 • 1,079 citations

A Meta-analysis of the Efficacy of Second-Generation Antipsychotics

2003 • 1,008 citations

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors

2002 • 896 citations

Efficacy and Safety of Aripiprazole and Haloperidol Versus Placebo in Patients With Schizophrenia and Schizoaffective Disorder

2002 • 624 citations

Aripiprazole, an Antipsychotic With a Novel Mechanism of Action, and Risperidone vs Placebo in Patients With Schizophrenia and Schizoaffective Disorder

2003 • 591 citations

The antipsychotic aripiprazole is a potent, partial agonist at the human 5-HT1A receptor

2002 • 506 citations

Aripiprazole in the treatment of schizophrenia: safety and tolerability in short-term, placebo-controlled trials

2003 • 472 citations

Interactions of the Novel Antipsychotic Aripiprazole (OPC-14597) with Dopamine and Serotonin Receptor Subtypes

1999 • 407 citations

Efficacy and safety of aripiprazole vs. haloperidol for long-term maintenance treatment following acute relapse of schizophrenia

2003 • 310 citations

Aripiprazole for the Prevention of Relapse in Stabilized Patients With Chronic Schizophrenia

2003 • 308 citations

7-(4-[4-(2,3-Dichlorophenyl)-1-piperazinyl]butyloxy)-3,4-dihydro-2(1H)-quinolinone (OPC-14597), a new putative antipsychotic drug with both presynaptic dopamine autoreceptor agonistic activity and postsynaptic D2 receptor antagonistic activity.

1995 • 268 citations

Switching patients to aripiprazole from other antipsychotic agents: a multicenter randomized study

2003 • 252 citations

Partial Compliance and Patient Consequences in Schizophrenia

2003 • 202 citations

A Pilot Study of Barriers to Medication Adherence in Schizophrenia

2004 • 174 citations

Effectiveness of Switching to Ziprasidone for Stable but Symptomatic Outpatients With Schizophrenia

2003 • 132 citations

Mechanism of Action of Aripiprazole Predicts Clinical Efficacy and a Favourable Side-Effect Profile

2004 • 130 citations

Aripiprazole: profile on efficacy and safety

2002 • 126 citations

Defining and Measuring Clinical Effectiveness in the Treatment of Schizophrenia

2005 • 117 citations

Switching antipsychotic medications.

1997 • 84 citations

Comparative efficacy of antipsychotics in the treatment of schizophrenia: A critical assessment

2005 • 82 citations

Long-acting injectable risperidone: safety and efficacy in stable patients switched from conventional depot antipsychotics

2004 • 79 citations

Aripiprazole in schizophrenia: consensus guidelines

2005 • 64 citations

Definition, Psychopharmacological Basis and Clinical Evaluation of Novel/Atypical Neuroleptics: Methodological Issues and Clinical Consequences

2000 • 59 citations

Risperidone versus Conventional Antipsychotics for Schizophrenia and???Schizoaffective Disorder

2004 • 52 citations

Validation of the Investigator's Assessment Questionnaire, a new clinical tool for relative assessment of response to antipsychotics in patients with schizophrenia and schizoaffective disorder

2005 • 40 citations

Efficacy and tolerability of quetiapine in patients with schizophrenia switched from other antipsychotics

2003 • 38 citations

Symptom correlates of global measures of severity in schizophrenia

1999 • 25 citations

Clinical Trials in Psychiatry: Do Results Apply to Practice?

2001 • 25 citations

Clinical effectiveness in first-episode patients

2004 • 24 citations

A Simple Switching Strategy for Inadequately Treated Patients with Schizophrenia to Olanzapine: Changes in Psychopathology and Subjective Well-being

2005 • 23 citations

Comparing efficacy of first-line atypical antipsychotics: no evidence of differential efficacy between risperidone, olanzapine, quetiapine, ziprasidone, and aripiprazole

2005 • 22 citations

Clinical effectiveness in adults with chronic schizophrenia

2004 • 20 citations

Cited By (0)

Loading...